Insulinoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Insulinoma}} | {{Insulinoma}} | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}; {{AE}} {{PSD}} | ||
==Overview== | ==Overview== | ||
There are no secondary | There are no established measures for the secondary prevention of [disease name]. | ||
OR | |||
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no secondary | *There are no established measures for the secondary prevention of [disease name]. | ||
OR | |||
*Effective measures for the secondary prevention of [disease name] include: | |||
**[Strategy 1] | |||
**[Strategy 2] | |||
**[Strategy 3] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
{{ | |||
{{ |
Revision as of 22:18, 10 August 2017
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma secondary prevention On the Web |
American Roentgen Ray Society Images of Insulinoma secondary prevention |
Risk calculators and risk factors for Insulinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- There are no established measures for the secondary prevention of [disease name].
OR
- Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]